Marcos André Cavalcanti Bezerra

Prof. Marcos André Cavalcanti Bezerra


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
JBJéssica V. G. F. Batista
Jéssica V. G. F. Batista
GAGabriela S. Arcanjo
Gabriela S. Arcanjo
TBThais H. C. Batista
Thais H. C. Batista
MSMarcondes J. Sobreira
Marcondes J. Sobreira
RSRodrigo M. Santana
Rodrigo M. Santana
MBMarcos André Cavalcanti Bezerra
Marcos André Cavalcanti Bezerra

18 April 2013 in Hemoglobin
Verified
Journal Article
Closed access
PDF file
GGGislene P. Gil
Gislene P. Gil
GAGalina Ananina
Galina Ananina
MOMariana B. Oliveira
Mariana B. Oliveira
FCFernando - prédio II - lab. Inflamação Ferreira Costa
Fernando - prédio II - lab. Inflamação Ferreira Costa
MSMárcio J. Silva
Márcio J. Silva
MMMônica B. Melo
Mônica B. Melo
The aim of this study was to investigate the association between three polymorphisms involved in the oxidative stress pathway and fetal hemoglobin (Hb F) levels in patients with sickle cell anemia in a Brazilian population. One hundred and seven patients with sickle cell anemia were recruited for genomic DNA extraction. The levels of Hb F, sex and age were evaluated. Three polymorphisms, rs4673:T>C and rs9932581:G>A in the CYBA gene and rs2071746:A>T in the HMOX1 gene, were identified through direct sequencing. Hb F levels were not associated with sex, age, or the polymorphisms rs4673:T>C and rs9932581:G>A. However, the TT genotype of the rs2071746:A>T polymorphism was associated with increased levels of Hb F (p value = 0.0131). We observed an association between the TT genotype of the rs2071746:A>T polymorphism, present in the HMOX1 gene, and increased levels of Hb F, indicating the presence of a new marker related to Hb F levels in sickle cell anemia patients.

1 September 2012 in Genetic Testing and Molecular Biomarkers
Verified
Journal Article
Closed access
BHBetânia L. D. Hatzlhofer
Betânia L. D. Hatzlhofer
MBMarcos André Cavalcanti Bezerra
Marcos André Cavalcanti Bezerra
MSMagnun N.N. Santos
Magnun N.N. Santos
DADulcinéia Albuquerque
Dulcinéia Albuquerque
EFElizabete M. Freitas
Elizabete M. Freitas
MMMaria Tereza Cartaxo Muniz
Maria Tereza Cartaxo Muniz
Vaso-occlusion is a determinant for most signs and symptoms of sickle-cell anemia (SCA). The mechanisms involved in the pathogenesis of vascular complications in SCA remain unclear. It is known that genetic polymorphisms associated with thrombophilia may be potential modifiers of clinical features of SCA. The genetic polymorphisms C677T and A1298C relating to the enzyme methylenetetrahydrofolate reductase (MTHFR), a clotting Factor V Leiden mutation (1691G→A substitution of Factor V Leiden), and the mutant prothrombin 20210A allele were analyzed in this study. The aim was to find possible correlations with vascular complications and thrombophilia markers in a group of SCA patients in Pernambuco, Brazil. The study included 277 SCA patients, divided into two groups: one consisting of 177 nonconsanguineous SCA patients who presented vascular manifestations of stroke, avascular necrosis, leg ulcers, priapism, and acute chest syndrome (group 1); and the other consisting of 100 SCA patients without any reported vascular complication (group 2). Molecular tests were done using either polymerase chain reaction (PCR) restriction fragment length polymorphism or allele-specific PCR techniques. Comparisons between the groups were made using the χ2 test. The 677 CT and TT genotypes showed a significant risk of vascular complications (p=0.015). No significant associations between the groups were found when samples were analyzed for the MTHFR A1298C allele (p=0.913), Factor V G1691 (p=0.555), or prothrombin G20210A mutation (p=1.000). The polymorphism MTHFR C677T seemed to be possibly predictive for the development of some vascular complications in SCA patients among this population.

28 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
HAHallysson Douglas Andrade de Araújo
Hallysson Douglas Andrade de Araújo
JJJosé G. Silva Júnior
José G. Silva Júnior
JOJoao Ricardhis Saturnino de Oliveira
Joao Ricardhis Saturnino de Oliveira
MRMaria Helena M. L. Ribeiro
Maria Helena M. L. Ribeiro
MMMonica Cristina Barroso Martins
Monica Cristina Barroso Martins
VLVera Lucia de Menezes Lima
Vera Lucia de Menezes Lima
To obtain usnic acid potassium salt (PS-UA), the usnic acid (UA) was extracted and purified from the lichen Cladonia substellata, and modified to produce PS-UA. The structure was determined by 1H-NMR, IR and elemental analysis, ratified through computational models, as well as identification the site of K+ insertion in the molecule. Antinociceptive activity was detected through contortions in mice induced by acetic acid and formalin (phases I and II) after treatments with 10 and 20 mg/kg of PS-UA, indicating interference in both non-inflammatory and inflammatory pain. After oral administration at doses of 500, 1000 and 2000 mg/kg, no deaths of mice with treatments below 2000 mg/kg were observed. Except for body weight gain, food and water consumption decreased with treatments of 1000 and 2000 mg/kg, and the number of segmented leukocytes was higher for both treatments. Regarding serum levels, cholesterol and triglycerides decreased, however, there was an increase in hepatic transaminases with both treatments. Liver and kidney histological changes were detected in treatments of 2000 mg/kg, while the spleen was preserved. The PS-UA demonstrated antinociceptive activity while the acute toxicity at the concentration of 2000 mg/kg was the only dose that presented morphological changes in the liver and kidney.

14 June 2021 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
JBJéssica V. G. F. Batista
Jéssica V. G. F. Batista
DPDiego A. Pereira-Martins
Diego A. Pereira-Martins
DFDiego A. Falcão
Diego A. Falcão
IDIgor F. Domingos
Igor F. Domingos
GAGabriela S. Arcanjo
Gabriela S. Arcanjo
MBMarcos André Cavalcanti Bezerra
Marcos André Cavalcanti Bezerra

4 January 2022 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
TBThais H. C. Batista
Thais H. C. Batista
RSRodrigo M. Santana
Rodrigo M. Santana
MSMarcondes J. Sobreira
Marcondes J. Sobreira
GAGabriela S. Arcanjo
Gabriela S. Arcanjo
IDIgor F. Domingos
Igor F. Domingos
MBMarcos André Cavalcanti Bezerra
Marcos André Cavalcanti Bezerra
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.